Trovafloxacin Mesylate Patent Expiration
Trovafloxacin Mesylate is Used for treating bacterial infections. It was first introduced by Pfizer Central Research
Trovafloxacin Mesylate Patents
Given below is the list of patents protecting Trovafloxacin Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Trovan | US6187341 | Trovafloxacin mesylate tablet |
Jan 20, 2019
(Expired) | Pfizer |
| Trovan | US5763454 | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Jun 15, 2015
(Expired) | Pfizer |
Trovafloxacin Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List